Participation in neuro-oncological trials from the participants' perspective
Conditions
Interventions
Group 1: After establishing an individual interview schedule, we will conduct at least one and up to four interviews with patients with brain tumour who agreed or declined to participate in a clinical
Sponsors
Neurologische Klinik Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Staff: staff members who are or have been involved in providing medical care for neuro-oncological patients at Heidelberg University Hospital. This includes but is not limited to physicians, researchers, caregivers, therapists, study nurses and management staff. Patients and relatives: Patients with brain tumour who are or have been in treatment at Heidelberg University Hospital as well as their relatives and other members of their support network. Relatives and other members of the patient's support network can be recruited even if the patient themself does not participate or is no longer able to participate.
Exclusion criteria
Exclusion criteria: Staff members: age under 18 years old, not fluent in German, no consent to participate in the study, without capacity to give informed consent Patients and relatives (or other members of their support network): age under 18 years old, not fluent in German, no consent to participate in the study, without capacity to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary goal of the study is to answer the following research question: How do patients at Heidelberg University Hospital experience the processes around recruitment, decision-making and (non-) participation in neuro-oncological trials? | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary goal of the study is to answer the following research questions: -How do relatives of patients at Heidelberg University Hospital experience the processes around recruitment, decision-making and (non-) participation in neuro-oncological trials? -How do staff at Heidelberg University Hospital experience the recruitment, decision-making and (non-) participation in neuro-oncological trials? -How does the Covid-19 pandemic affect trial participation by neuro-oncological patients? | — |
Countries
Germany
Contacts
Public ContactLoraine Busetto
Neurologische Klinik Universitätsklinikum Heidelberg
Outcome results
None listed